Bioceres Crop Solutions (NASDAQ:BIOX) Earns "Sell (D)" Rating from Weiss Ratings

Key Points

• Bioceres Crop Solutions has been given a "sell (D)" rating by Weiss Ratings, indicating a negative outlook for the stock's performance.
• Brokerages are increasingly pessimistic, with analysts downgrading the stock from "strong-buy" to "hold" and "sell" ratings, resulting in a consensus rating of "Hold" with an average target price of $4.17.
• Bioceres Crop Solutions' stock price dropped 7.5% to $1.84, reflecting significant market concerns, while the company has seen recent institutional investments increase its stake in the firm.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report)'s stock had its "sell (d)" rating reissued by Weiss Ratings in a research note issued on Friday,Weiss Ratings reports.

Several other brokerages have also commented on BIOX. Brookline Capital Management lowered Bioceres Crop Solutions from a "strong-buy" rating to a "hold" rating in a research report on Thursday, August 21st. Oppenheimer lowered Bioceres Crop Solutions from an "outperform" rating to a "market perform" rating in a research report on Wednesday. Lake Street Capital decreased their target price on Bioceres Crop Solutions from $8.00 to $5.00 and set a "buy" rating for the company in a research report on Wednesday, September 10th. Canaccord Genuity Group reiterated a "hold" rating and issued a $2.50 target price (down previously from $6.50) on shares of Bioceres Crop Solutions in a research report on Wednesday, September 10th. Finally, Wall Street Zen downgraded Bioceres Crop Solutions from a "hold" rating to a "sell" rating in a research note on Saturday, September 13th. One analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Bioceres Crop Solutions presently has a consensus rating of "Hold" and an average target price of $4.17.

Bioceres Crop Solutions Stock Down 7.5%

BIOX stock traded down $0.15 during midday trading on Friday, hitting $1.84. 532,387 shares of the company's stock were exchanged, compared to its average volume of 372,053. The stock has a market capitalization of $115.39 million, a price-to-earnings ratio of -2.27 and a beta of 0.33. The firm has a 50 day moving average price of $2.07 and a 200-day moving average price of $3.51. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 0.22. Bioceres Crop Solutions has a 12-month low of $1.20 and a 12-month high of $7.44.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in BIOX. Fourth Sail Capital LP boosted its position in Bioceres Crop Solutions by 25.1% during the 1st quarter. Fourth Sail Capital LP now owns 4,627,669 shares of the company's stock worth $21,125,000 after acquiring an additional 928,708 shares during the period. Allianz Asset Management GmbH lifted its holdings in shares of Bioceres Crop Solutions by 77.5% in the first quarter. Allianz Asset Management GmbH now owns 236,717 shares of the company's stock valued at $1,081,000 after buying an additional 103,337 shares during the period. Long Focus Capital Management LLC lifted its holdings in shares of Bioceres Crop Solutions by 11.4% in the first quarter. Long Focus Capital Management LLC now owns 829,748 shares of the company's stock valued at $3,788,000 after buying an additional 85,000 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Bioceres Crop Solutions by 9.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company's stock valued at $3,761,000 after buying an additional 71,581 shares during the period. Finally, Maven Securities LTD lifted its holdings in shares of Bioceres Crop Solutions by 242.7% in the first quarter. Maven Securities LTD now owns 85,673 shares of the company's stock valued at $391,000 after buying an additional 60,673 shares during the period. Institutional investors and hedge funds own 17.68% of the company's stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.